These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32960986)

  • 1. Population Pharmacokinetics of Phenobarbital in Neonates and Infants on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Thibault C; Massey SL; Abend NS; Naim MY; Zoraian A; Zuppa AF
    J Clin Pharmacol; 2021 Mar; 61(3):378-387. PubMed ID: 32960986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation.
    Pokorná P; Šíma M; Vobruba V; Tibboel D; Slanař O
    Perfusion; 2018 May; 33(1_suppl):80-86. PubMed ID: 29788839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation.
    Elliott ES; Buck ML
    Ann Pharmacother; 1999 Apr; 33(4):419-22. PubMed ID: 10332532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetics of IV Phenobarbital in Neonates After Congenital Heart Surgery.
    Thibault C; Massey SL; Naim MY; Abend NS; Zuppa AF
    Pediatr Crit Care Med; 2020 Aug; 21(8):e557-e565. PubMed ID: 32224827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants: an update.
    Yukawa M; Yukawa E; Suematsu F; Takiguchi T; Ikeda H; Aki H; Mimemoto M
    J Clin Pharm Ther; 2011 Dec; 36(6):704-10. PubMed ID: 22023343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Increase in Clearance of Phenobarbital in Neonates on Extracorporeal Membrane Oxygenation: A Pilot Retrospective Population Pharmacokinetic Analysis.
    Michaličková D; Pokorná P; Tibboel D; Slanař O; Knibbe CAJ; Krekels EHJ
    Pediatr Crit Care Med; 2020 Sep; 21(9):e707-e715. PubMed ID: 32639476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual Meropenem Clearance in Infants on ECMO and CVVHDF is Difficult to Predict: A Case Report and Review of the Literature.
    Jabareen A; Nassar L; Karasik M; Efrati E; Hadash A; Kassis I; Kurnik D
    Pediatr Infect Dis J; 2022 Feb; 41(2):117-120. PubMed ID: 34966143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
    Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Levkovich BJ; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Roberts JA; Shekar K; Fraser JF;
    Anaesth Crit Care Pain Med; 2022 Jun; 41(3):101080. PubMed ID: 35472580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
    Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
    Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach.
    Marsot A; Brevaut-Malaty V; Vialet R; Boulamery A; Bruguerolle B; Simon N
    Fundam Clin Pharmacol; 2014 Aug; 28(4):465-71. PubMed ID: 23855753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.
    Ahsman MJ; Hanekamp M; Wildschut ED; Tibboel D; Mathot RA
    Clin Pharmacokinet; 2010 Jun; 49(6):407-19. PubMed ID: 20481651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration.
    Kleiber N; Mathôt RAA; Ahsman MJ; Wildschut ED; Tibboel D; de Wildt SN
    Br J Clin Pharmacol; 2017 Jun; 83(6):1227-1239. PubMed ID: 28078682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation.
    Watt KM; Gonzalez D; Benjamin DK; Brouwer KL; Wade KC; Capparelli E; Barrett J; Cohen-Wolkowiez M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3935-43. PubMed ID: 25896706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
    Garbez N; Mbatchi LC; Maseda E; Luque S; Grau S; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
    Ther Drug Monit; 2021 Dec; 43(6):747-755. PubMed ID: 33560097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF).
    Kirwan M; Munshi R; O'Keeffe H; Judge C; Coyle M; Deasy E; Kelly YP; Lavin PJ; Donnelly M; D'Arcy DM
    Crit Care; 2021 Dec; 25(1):443. PubMed ID: 34930430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
    Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
    J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic/pharmacodynamic evaluations of amikacin dosing in critically ill patients undergoing continuous venovenous hemodiafiltration.
    Li S; Zhu S; Xie F
    J Pharm Pharmacol; 2023 Apr; 75(4):515-522. PubMed ID: 36847263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.